SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
1493 51 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1352over 200million volume [over 2/3 of float ] and short volume was 120M dec 2025..urslor-January 20
1351IBRX just had its strongest rally since Anktiva was approved 2 years ago. The voOlecranon1January 20
1350I love Amarone’s!jargonweary-January 20
1349are you the reason for the monster volume?urslor-January 20
1348I did the same. Feels like easy money. Let’s hope it stays that wayzagnut1-January 20
1347Sold some $5 and $5.5 puts, which is what I tend to do when I am bullish, premiughettogoulash-January 20
1346This is actually good news-- FDA is apparently open to discussions now. Last I hghettogoulash6January 20
1345time for another Amarone tonight...urslor2January 20
1344probably going to have to raise it again tomorrow.... lolerippetoe1January 20
1343This morning: Piper Sandler analyst Joseph Catanzaro maintains ImmunityBio(IBRluckydog881January 20
1342Looks like this is why the stock lost momentum early this morning - also explainluckydog882January 20
1341The price also shows on yahoo finance and seems to be updating a lot so appears erippetoe-January 19
1340just for informational purposes, and things will change greatly before the morniluckydog882January 19
1339This probably only happens with tiered pricing. Retain the J-code for oncology. ghettogoulash-January 19
1338Furthermore, Anktiva would have no biosimilar competition to lower the price. Myghettogoulash-January 19
1337Looks like IBRX closed at $7.77 (6.70 euros) in Europeerippetoe-January 19
1336"Bioshield" sounds like something Elon Musk would come up with, so I nghettogoulash-January 19
1335Can be some good info at reddit.com too but a lot of spam and noise over the laserippetoe-January 19
1334That’s euros so still 7+. Exchange rate is 1.16 so 6.02 on that site is $7erippetoe1January 19
1333I was looking into that too but from what I can see the volume is tiny and the pluckydog881January 19
1332Trading at $7+ in Europe. See ls-tc.de which is in euroserippetoe-January 19
1331I find the Bioshield take on Anktiva a bit of a stretch given where it's at waitwatchwander-January 18
1330Pancreatic cancer is an area PSS has been working on for decades. With that forwaitwatchwander-January 18
1329I'm not sure that link is working. Ask AI, "Is ImmunityBio pursuing appghettogoulash1January 17
1328I just realized something BIG. ImmunityBio is pursuing approval of Anktiva in chghettogoulash-January 17
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News